OpACIN-neo: A multicenter phase II study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO) — Christian U. Blank (2018) | RDL Network
Elisa A. Rozeman, Alexander Christopher Jonathan Van Akkooi, Émilie Routier, Alexander M. Menzies, Hanna Eriksson, Myles Smith, Richard A Scolyer, Christoph Höeller, Johan Hansson, Caroline Robert, James Larkin, Georgina V. Long, Christian U. Blank
Elisa A. Rozeman, Alexander Christopher Jonathan Van Akkooi, Alexander M. Menzies, Myles Smith, Richard A Scolyer, Loes M. Pronk, Maria Gonzales, Christoph Höeller, Johan Hansson, James Larkin, Georgina V. Long, Christian U. Blank
Elisa A. Rozeman, Irene L. M. Reijers, Esmée P. Hoefsmit, Karolina Sikorska, Oscar Krijgsman, Bart A. van de Wiel, Petros Dimitriadis, Hanna Eriksson, Maria Gonzalez, Lindsay G. Grijpink-Ongering, Ron Kerkhoven, Annegien Broeks, W. Martin C. Klop, Andrew J. Spillane, Robyn P.M. Saw, Alexander Christopher Jonathan Van Akkooi, Richard A Scolyer, Alexander M. Menzies, Georgina V. Long, Christian U. Blank
Irene L. M. Reijers, Elisa A. Rozeman, Alexander M. Menzies, Judith M. Versluis, Bart A. van de Wiel, Karolina Sikorska, Hanna Eriksson, Kerwin F. Shannon, Carolien Bierman, Harm van Tinteren, Maria Gonzalez, Andrew J. Spillane, Robyn P.M. Saw, Richard A Scolyer, Alexander C.J. van Akkooi, Johan Hansson, Georgina V. Long, Christian U. Blank
Rebecca Simpson, M. Batten, E.R. Shanahan, I. Pires da Silva, J.M. Versluis, I.L.M. Reijers, A.M. Menzies, R.P.M. Saw, M. Gonzalez, Kerwin F. Shannon, Andrew J. Spillane, C.U. Blank, Richard A Scolyer, G.V. Long
Discussion(0)
No comments yet. Be the first to comment.